Royal Bank Of Canada Codex Dna, Inc. Transaction History

Royal Bank Of Canada

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	N/A	127 New	127 $0
Q1 2024 May 15, 2024	SELL	N/A	-123 Reduced 49.2%	127 $0
Q4 2023 Feb 14, 2024	BUY	N/A	183 Added 273.13%	250 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-295 Reduced 81.49%	67 $0
Q2 2023 Aug 14, 2023	BUY	N/A	359 Added 11966.67%	362 $0
Q1 2023 May 15, 2023	SELL	$1.3 - $2.15 $1 - $2	-1 Reduced 25.0%	3 $0
Q4 2022 Feb 14, 2023	SELL	$1.12 - $1.69 $220 - $332	-197 Reduced 98.01%	4 $0
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $341 - $474	201 New	201 $0
Q2 2022 Aug 15, 2022	SELL	$1.8 - $6.45 $1,011 - $3,624	-562 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.12 - $10.36 $14,864 - $37,378	-3,608 Reduced 86.52%	562 $3,000
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $20,343 - $38,559	3,224 Added 340.8%	4,170 $45,000
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $9,601 - $18,806	946 New	946 $10,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.